SFRP1 CpG island methylation locus is associated with renal cell cancer susceptibility and disease recurrence.
about
Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinomaGATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma.Neurofilament Heavy polypeptide CpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy response.Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma.Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy.
P2860
SFRP1 CpG island methylation locus is associated with renal cell cancer susceptibility and disease recurrence.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
SFRP1 CpG island methylation l ...... bility and disease recurrence.
@en
SFRP1 CpG island methylation l ...... bility and disease recurrence.
@nl
type
label
SFRP1 CpG island methylation l ...... bility and disease recurrence.
@en
SFRP1 CpG island methylation l ...... bility and disease recurrence.
@nl
prefLabel
SFRP1 CpG island methylation l ...... bility and disease recurrence.
@en
SFRP1 CpG island methylation l ...... bility and disease recurrence.
@nl
P2093
P2860
P356
P1433
P1476
SFRP1 CpG island methylation l ...... bility and disease recurrence.
@en
P2093
Annika Großhennig
Arnulf Stenzl
Axel S Merseburger
Faranaz Atschekzei
Inga Peters
Jörg Hennenlotter
Jürgen Serth
Markus A Kuczyk
Sandra Waalkes
Stefanie Jänisch
P2860
P304
P356
10.4161/EPI.19614
P50
P577
2012-05-01T00:00:00Z